![](/img/cover-not-exists.png)
Study Design of a Phase 3, Randomized, Open-Label, Multicenter Study to Evaluate Ruxolitinib Over BAT in Patients with Corticosteroid-Refractory Chronic Graft vs Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation (REACH-3)
Zeiser, Robert, Ram, Ron, Foley, Stephen Ronan, Yeshurun, Moshe, Locatelli, Franco, Artz, Andrew, Gadbaw, Brian, Atienza, Edric, Hollaender, Norbert, Delaite, Patricia, Teshima, TakanoriVolume:
24
Language:
english
Journal:
Biology of Blood and Marrow Transplantation
DOI:
10.1016/j.bbmt.2017.12.176
Date:
March, 2018
File:
PDF, 325 KB
english, 2018